Prolonged Remission in SLE Revisited: An Old Wine in a New Bottle

REFERENCES

1. 1.↵
   1. Steiman A,
   2. Urowitz MB,
   3. Ibanez D,
   4. Papneja A,
   5. Gladman DD

   . Prolonged clinical remission in patients with systemic lupus erythematosus. J Rheumatol 2014;41:1808–16.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Dubois EL,
   2. Tuffanelli DL

   . Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 1964;190:104–11.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Gladman DD,
   2. Urowitz MB,
   3. Keystone EC

   . Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features. Am J Med 1979;66:210–5.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Tozman EC,
   2. Urowitz MB,
   3. Gladman DD

   . Prolonged complete remission in previously severe SLE. Ann Rheum Dis 1982;41:39–40.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Heller CA,
   2. Schur PH

   . Serological and clinical remission in systemic lupus erythematosus. J Rheumatol 1985;12:916–8.

   OpenUrlPubMed
6. 6.↵
   1. Drenkard C,
   2. Villa AR,
   3. Garcia-Padilla C,
   4. Perez-Vazquez ME,
   5. Alarcon-Segovia D

   . Remission of systemic lupus erythematosus. Medicine 1996;75:88–98.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Urowitz MB,
   2. Feletar M,
   3. Bruce IN,
   4. Ibanez D,
   5. Gladman DD

   . Prolonged remission in systemic lupus erythematosus. J Rheumatol 2005;32:1467–72.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Steiman AJ,
   2. Gladman DD,
   3. Ibanez D,
   4. Urowitz MB

   . Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome. J Rheumatol 2010;37:1822–7.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Formiga F,
   2. Moga I,
   3. Pac M,
   4. Mitjavila F,
   5. Rivera A,
   6. Pujol R

   . High disease activity at baseline does not prevent a remission in patients with systemic lupus erythematosus. Rheumatology 1999;38:724–7.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Cooper GS,
    2. Treadwell EL,
    3. St Clair EW,
    4. Gilkeson GS,
    5. Dooley MA

    . Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus. Arthritis Rheum 2007;57:993–9.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Calvo-Alén J,
    2. Reveille JD,
    3. Rodríguez-Valverde V,
    4. McGwin G Jr.,
    5. Baethge BA,
    6. Friedman AW,
    7. et al.

    Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus 2003;12:377–85.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Pons-Estel BA,
    2. Catoggio LJ,
    3. Cardiel MH,
    4. Soriano ER,
    5. Gentiletti S,
    6. Villa AR,
    7. et al.

    The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics”. Medicine 2004;83:1–17.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Zen M,
    2. Bassi N,
    3. Nalotto L,
    4. Canova M,
    5. Bettio S,
    6. Gatto M,
    7. et al.

    Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study. Clin Exp Rheumatol 2012;30:856–63.

    OpenUrlPubMed
14. 14.↵
    1. Ugarte-Gil MF,
    2. Acevedo-Vásquez E,
    3. Alarcón GS,
    4. Pastor-Asurza CA,
    5. Alfaro-Lozano JL,
    6. Cucho-Venegas JM,
    7. et al.

    The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort. Ann Rheum Dis 2014; Feb 13 (E-pub ahead of print).
15. 15.↵
    1. van Vollenhoven RF,
    2. Mosca M,
    3. Bertsias G,
    4. Isenberg D,
    5. Kuhn A,
    6. Lerstrøm K,
    7. et al.

    Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 2014;73:958–67.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Bootsma H,
    2. Spronk P,
    3. Derksen R,
    4. de Boer G,
    5. Wolters-Dicke H,
    6. Hermans J,
    7. et al.

    Prevention of relapses in systemic lupus erythematosus. Lancet 1995;345:1595–9.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Tseng CE,
    2. Buyon JP,
    3. Kim M,
    4. Belmont HM,
    5. Mackay M,
    6. Diamond B,
    7. et al.

    The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006;54:3623–32.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Pons-Estel GJ,
    2. Alarcon GS,
    3. Burgos PI,
    4. Hachuel L,
    5. Boggio G,
    6. Wojdyla D,
    7. et al.

    Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort. Lupus 2013;22:899–907.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Ruiz-Irastorza G,
    2. Egurbide MV,
    3. Pijoan JI,
    4. Garmendia M,
    5. Villar I,
    6. Martinez-Berriotxoa A,
    7. et al.

    Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 2006;15:577–83.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Shinjo SK,
    2. Bonfa E,
    3. Wojdyla D,
    4. Borba EF,
    5. Ramirez LA,
    6. Scherbarth HR,
    7. et al.

    Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort. Arthritis Rheum 2010;62:855–62.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Alarcon GS,
    2. McGwin G,
    3. Bertoli AM,
    4. Fessler BJ,
    5. Calvo-Alén J,
    6. Bastian HM,
    7. et al.

    Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis 2007;66:1168–72.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Barr SG,
    2. Zonana-Nacach A,
    3. Magder LS,
    4. Petri M

    . Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum 1999;42:2682–8.

    OpenUrlCrossRefPubMed